Top Clinical Trials companies in Germany by Operating Income Margin
Germany
# |
Name |
Operating Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
20.96%
|
Dec. 31, 2023 | USD 42.00 | -2.04% |
|
Germany |
|
| 2 |
-0.47%
|
Dec. 31, 2023 | USD 54.35 | -2.09% |
|
Germany |
|
| 3 |
-188.39%
|
Dec. 31, 2023 | USD 5.47 | 1.30% |
|
Germany |
|
| 4 |
-215.13%
|
Nov. 30, 2023 | USD 2.38 | -3.93% |
|
Germany |
|
| 5 |
-2,975.47%
|
Dec. 31, 2023 | USD 6.92 | 13.63% |
|
Germany |
|
| 6 |
-39,958.92%
|
Dec. 31, 2023 | USD 1.55 | -3.12% |
|
Germany |
|
| 7 |
-71,182.13%
|
Dec. 31, 2023 | USD 2.41 | 1.69% |
|
Germany |
Frequently Asked Questions
-
Which Clinical Trials company in Germany has the highest Operating Income Margin ?
The Clinical Trials company in Germany with the highest Operating Income Margin is Biotest AG (XETRA: BIO.DE) at 20.96%.
-
Which Clinical Trials company in Germany has the lowest Operating Income Margin ?
The Clinical Trials company in Germany with the lowest Operating Income Margin is InflaRx N.V. (NasdaqGS: IFRX) at -71,182.13%.
-
What are the top 10 Clinical Trials companies in Germany by Operating Income Margin ?
The top 10 Clinical Trials companies in Germany by Operating Income Margin are Biotest AG, Formycon AG, Immatics N.V., Heidelberg Pharma AG, Mainz Biomed B.V., Atai Life Sciences N.V. and InflaRx N.V..
-
What are the bottom 10 Clinical Trials companies in Germany by Operating Income Margin ?
The bottom 10 Clinical Trials companies in Germany by Operating Income Margin are InflaRx N.V., Atai Life Sciences N.V., Mainz Biomed B.V., Heidelberg Pharma AG, Immatics N.V., Formycon AG and Biotest AG.
